These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 194476)

  • 1. Prevention or modification of varicella using zoster immune plasma.
    Balfour HH; Groth KE; McCullough J; Kalis JM; Marker SC; Nesbit ME; Simmons RL; Najarian JS
    Am J Dis Child; 1977 Jun; 131(6):693-6. PubMed ID: 194476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of zoster immune plasma. Treatment of cutaneous disseminated zoster in immunocompromised patients.
    Groth KE; McCullough J; Marker SC; Howard RJ; Simmons RL; Najarian JS; Balfour HH
    JAMA; 1978 May; 239(18):1877-9. PubMed ID: 205687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients.
    Hanngren K; Falksveden L; Grandien M; Lidin-Janson G
    Scand J Infect Dis; 1983; 15(4):327-34. PubMed ID: 6318302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoster immune plasma prophylaxis of varicella: a follow-up report.
    Balfour HH; Groth KE
    J Pediatr; 1979 May; 94(5):743-6. PubMed ID: 221631
    [No Abstract]   [Full Text] [Related]  

  • 5. Varicella-zoster antibody titers in children with leukemia and lymphoma. Relationship of titer to varicella-zoster infection.
    Hutter JJ; Minnich LL; Ray CG
    Am J Dis Child; 1984 Jan; 138(1):56-9. PubMed ID: 6318551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.
    Miller E; Cradock-Watson JE; Ridehalgh MK
    Lancet; 1989 Aug; 2(8659):371-3. PubMed ID: 2569560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization against varicella in sick neonates by transfusion from donors immunologically enhanced by previous vaccination with live varicella vaccine.
    Isomura S; Nagai H; Kuroyanagi M; Horizawa S; Takahashi M
    Biken J; 1984 Sep; 27(2-3):133-6. PubMed ID: 6100051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human anti-chickenpox immunoglobulin in the prevention of chickenpox.
    Evans EB; Pollock TM; Cradock-Watson JE; Ridehalgh MK
    Lancet; 1980 Feb; 1(8164):354-6. PubMed ID: 6101802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should patients with zoster receive zoster immune globulin?
    Uduman SA; Gershon AA; Brunell PA
    JAMA; 1975 Dec; 234(10):1049-51. PubMed ID: 171458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to varicella-zoster virus after passive immunization against chickenpox.
    Gershon AA; Piomelli S; Karpatkin M; Smithwick E; Steinberg S
    J Clin Microbiol; 1978 Dec; 8(6):733-5. PubMed ID: 217893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An algorithm for the control of nosocomial varicella-zoster virus infection.
    Weitekamp MR; Schan P; Aber RC
    Am J Infect Control; 1985 Oct; 13(5):193-8. PubMed ID: 2998229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical reinfection with varicella-zoster virus.
    Gershon AA; Steinberg SP; Gelb L
    J Infect Dis; 1984 Feb; 149(2):137-42. PubMed ID: 6321605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program.
    Gans H; Chemaly RF
    BMC Infect Dis; 2021 Jan; 21(1):46. PubMed ID: 33430796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
    Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.